Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
India Life Sciences Fund III is a private equity fund managed by InvAscent that targets growth-stage investments in the Indian healthcare and life sciences sectors. The fund focuses on mid-market companies across diverse sub-sectors, including pharmaceuticals, medical devices, healthcare services, and animal health. With a total corpus of approximately $250 million, it provides capital for capacity expansion, product development, and geographic reach. The fund's investment strategy emphasizes partnering with high-growth enterprises that serve both the Indian domestic market and global export markets. Notable portfolio investments include specialized hospital chains and medical technology manufacturers. It is the third fund in a series of successful life sciences-focused investment vehicles managed by the InvAscent team.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on India Life Sciences Fund III.